Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvyn W Yap

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Retrovirology|June 26, 2016
Expression levels of Fv1: effects on retroviral restriction specificitiesWilson Li, Melvyn W Yap, Vicky Voss, et al.
Journal of Virology|July 30, 2005
Capsid processing requirements for abrogation of Fv1 and Ref1 restrictionMark P Dodding, Michael Bock, Melvyn W Yap, et al.
Plos Pathogens|March 8, 2014
Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retrovirusesMelvyn W Yap, Emily Colbeck, Scott A Ellis, et al.
Virology|May 12, 2007
The design of artificial retroviral restriction factorsMelvyn W Yap, Gulnahar B Mortuza, Ian A Taylor, et al.
Plos Genetics|June 12, 2020
Duplication and divergence of the retrovirus restriction gene Fv1 in Mus caroli allows protection from multiple retrovirusesMelvyn W Yap, George R Young, Renata Varnaite, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Evolutionary journey of the retroviral restriction gene <i>Fv1</i>George R Young, Melvyn W Yap, Johan R Michaux, et al.
Plos Pathogens|April 13, 2011
Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid proteinSadayuki Ohkura, David C Goldstone, Melvyn W Yap, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factorsHarriet C T Groom, Melvyn W Yap, Rui Pedro Galão, et al.
Journal of Virology|July 29, 2006
Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1Kate N Bishop, Gulnahar B Mortuza, Steven Howell, et al.
Plos Pathogens|August 25, 2022
SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA exportRoss Hall, Anabel Guedán, Melvyn W Yap, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Retrovirology|June 26, 2016
Expression levels of Fv1: effects on retroviral restriction specificitiesWilson Li, Melvyn W Yap, Vicky Voss, et al.
Journal of Virology|July 30, 2005
Capsid processing requirements for abrogation of Fv1 and Ref1 restrictionMark P Dodding, Michael Bock, Melvyn W Yap, et al.
Plos Pathogens|March 8, 2014
Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retrovirusesMelvyn W Yap, Emily Colbeck, Scott A Ellis, et al.
Virology|May 12, 2007
The design of artificial retroviral restriction factorsMelvyn W Yap, Gulnahar B Mortuza, Ian A Taylor, et al.
Plos Genetics|June 12, 2020
Duplication and divergence of the retrovirus restriction gene Fv1 in Mus caroli allows protection from multiple retrovirusesMelvyn W Yap, George R Young, Renata Varnaite, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Evolutionary journey of the retroviral restriction gene <i>Fv1</i>George R Young, Melvyn W Yap, Johan R Michaux, et al.
Plos Pathogens|April 13, 2011
Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid proteinSadayuki Ohkura, David C Goldstone, Melvyn W Yap, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factorsHarriet C T Groom, Melvyn W Yap, Rui Pedro Galão, et al.
Journal of Virology|July 29, 2006
Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1Kate N Bishop, Gulnahar B Mortuza, Steven Howell, et al.
Plos Pathogens|August 25, 2022
SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA exportRoss Hall, Anabel Guedán, Melvyn W Yap, et al.
Pageof 3